Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.97
-0.05 (-4.90%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.01
+0.04 (4.12%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Senti Biosciences Holdings, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, davolash mumkin bo'lmagan kasalliklari bo'lgan bemorlar uchun o'zining gen sxemasi platformasi texnologiyalari bilan ishlab chiqilgan hujayra va gen terapiyalarini ishlab chiqadi. Kompaniyaning asosiy mahsulot nomzodlari, foydalanilmagan ehtiyojlari bo'lgan turli onkologik ko'rsatkichlar uchun gen sxemasi texnologiyalari bilan jihozlangan CAR-NK hujayralarini yaratish uchun tayyor sog'lom kattalar donorlaridan olingan tabiiy killer (NK) hujayralaridan foydalanadi. U qon saratoni va o'tkir miyeloid leykemiya, shu jumladan, qaytalangan/refrakter gematologik malignansiyalarni davolash uchun mantiqiy darajali tayyor CAR-NK hujayra terapiyasi bo'lgan SENTI-202 ni taklif etadi. Bundan tashqari, kompaniya saraton hujayralaridagi NOT GATE antigen nomzodlarini tanlash va tasdiqlash hamda o'simtaga bog'liq antigenlarni aniqlash uchun o'simtaga bog'liq antigen va himoya antigen juftligini kashf qilish platformasini ishlab chiqadi. Bundan tashqari, uning quvurlarida preklinik dasturlar mavjud bo'lib, ular qattiq o'simta hujayra terapiyasi dasturini; va regenerativ tibbiyot uchun hujayra terapiyalariga oid hamkorlikdagi dasturlarni o'z ichiga oladi. Kompaniya Celest Therapeutics (Shanghai) Co. Ltd. bilan strategik hamkorlikka ega. Kompaniya ilgari Senti Biosciences, Inc. nomi bilan tanilgan va 2026 yil aprel oyida Senti Biosciences Holdings, Inc. nomini o'zgartirgan. Kompaniya 2016 yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Janubiy San-Frantsiskoda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James J. Collins Ph.D. | Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director |
| Dr. Kanya Rajangam M.D., Ph.D. | President, Head of Research & Development and Chief Medical Officer |
| Dr. Timothy K. Lu M.D., Ph.D. | Co-Founder, CEO & Director |
| Dr. Wilson Wong Ph.D. | Scientific Co-Founder & Member of Scientific Advisory Board |
| Mr. Faraz Siddiqui | Senior Vice President of Technical Operations |
| Mr. Jay Cross | Chief Financial Officer |
| Mr. Robert H. Cutler J.D. | Senior VP & Head of Legal Affairs |
| Mr. Thomas P. Chung | Vice President of Strategic Finance & Corporate Development |
| Ms. Dee Olomajeye Dragon | Senior VP of People & Culture Strategy & Head of Administrative Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 15-12G | d279858d1512g.htm |
| 2026-05-01 | 8-K | snti-20260427.htm |
| 2026-04-29 | 10-K/A | snti-20251231.htm |
| 2026-04-24 | S-8 | d147946ds8.htm |
| 2026-04-24 | POS AM | d148583dposam.htm |
| 2026-04-01 | 8-K | snti-20260401.htm |
| 2026-03-27 | 8-K | snti-20260327.htm |
| 2026-03-27 | 10-K | snti-20251231.htm |
| 2026-03-19 | 8-K | snti-20260317.htm |
| 2025-12-09 | 8-K | snti-20251209.htm |